Chicken anemia virus (CAV) is a serious viral infection that causes considerable impairment of immunity and severe anemia in chickens all over the world. In young chicks, significant illness and mortality are observed (2–3 weeks). The vertical route of transmission enhances the chance of infection and virus persistence among diseased flocks. This research aimed to confirm the existence of CAV in young chicks (at the age of 1–7 days) in Egypt during 2021, genetic divergence between the spreading viruses and vaccinal strains in order to improve virus control. DNA was isolated from samples that were collected, used in a targeting VP2 gene by PCR, and then characterized VP2 on a molecular level in the detected viruses. Five CAV were detected, sequenced, and submitted to Genebank under accession no MZ574095, MZ574096, MZ476999, MZ477000, MZ477001. The strains were classified into genogroups I, II, and IIIb, and one detected strain was congregated with the vaccinal strain 26P4 and Nobilis P4. Also, the VP2 protein of the five CAV isolates and Egyptian CAV showed a high Conservation score. In silico analysis of the secondary structures of VP2 proteins of Cux-1 (reference strain) and the five strains showed that the a-helix and ß-strand architectures were quite comparable in number and position. As well as, VP2 of the five CAV isolates showed the absence of an insertion or a deletion in comparison to Cux-1 in the sequenced part.